Summary
Theophylline concentrations were measured in a clinical setting in 15 patients given a slow release theophylline preparation (Theo-Dur) every 12 h for reversible obstructive airways disease. Doses of 300–600 mg (464±134), 12 hourly, resulted in mean serum concentrations which increased from 11.2±2.9 µg/ml at 0 h to a peak of 15.5±4.6 µg/ml at 6 h and decreased again to 10.4±2.9 µg/ml at 12 h. The mean percentage fluctuation of serum concentrations (maximum minus minimum expressed as a % of the maximum) was 38.6±10.1%, range 20.3% to 54.9%. There was a significant positive correlation between % fluctuation and theophylline steady-state clearance determinations. Excluding a single heavy smoker, theophylline clearance also showed a significant inverse relationship with age. These data suggest that when this slow release preparation is given 12 hourly, satisfactorily sustained serum theophylline concentrations will be achieved in most adults.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ogilvie RI (1976) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3: 267–293
Hendeles L, Weinberger M, Johnson G (1976) Monitoring serum theophylline levels. Clin Pharmacokinet 3: 294–312
Mitenko PA, Ogilvie RI (1973) Rational intravenous doses of theophylline. N Engl J Med 289: 600–603
Levy G, Koysooko R (1975) Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr 86: 789–793
Weinberger M, Hendeles L, Bighley L (1978) The relation of product formulation to absorption of oral theophylline. N Engl J Med 299: 852–857
Spangler DL, Kalof DD, Bloom FL, Wittig HJ (1978) Theophylline bioavailability following oral administration of six sustained release preparations. Ann Allergy 40: 6–11
Dasta J, Mirtallo JM, Altman M (1979) Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease. Am J Hosp Pharm 36: 613–617
Urquhart N, Godolphin W, Campbell DJ (1979) Evaluation of automated enzyme immunoassays for five anticonvulsants and theophylline adapted to a centrifugal analyzer. Clin Chem 25: 785–787
Hendeles L, Weinberger M, Bighley L (1978) Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis 118: 97–103
Powell JR, Vozeh S, Hopewell P, Costello J, Sheiner LB, Riegelman S (1978) Theophylline disposition in acutely ill hospitalised patients: The effect of smoking, heart failure, severe airway obstruction, and pneumonia. Am Rev Respir Dis 118: 229–238
Antal EJ, Kramer PA, Mercik SA, Chapron DJ, Lawson IR (1981) Theophylline pharmacokinetics in advanced age. Br J Clin Pharmacol 12: 637–645
Richer C, Mathieu M, Bah H, Thuillez C, Duroux P, Giudicelli JF (1982) Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin. Clin Pharmacol Ther 31: 579–586
Roberts RK, Grice J, Wood L, Petroff V, McGuffie C (1981) Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19–21
Lesko LJ, Brousseau D, Canada AT, Eastwood G (1980) Temporal variations in trough serum theophylline concentrations at steady state. J Pharm Sci 69: 358–359
Scott PH, Tabachnik E, MacLeod S, Correia J, Newth C, Levison H (1981) Sustained release theophylline for childhood asthma: Evidence for circadian variation of theophylline pharmacokinetics. J Pediatr 99: 476–479
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jackson, S.H.D., Wright, J.M. Sustained serum theophylline concentrations during chronic twice daily administration of a slow release preparation. Eur J Clin Pharmacol 24, 205–208 (1983). https://doi.org/10.1007/BF00613818
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00613818